Top Markets
#1 Islamic Coin Islamic Coin +151.53%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +17.95%
#3 Palladium Network Palladium Network +14.30%
#4 clBTC clBTC +12.18%
#5 Not in Employment, Education, or Training Not in Employment, Education, or Training +9.58%
#6 OpenEden OpenEden +9.30%
#7 Wrapped Ether (Mantle Bridge) Wrapped Ether (Mantle Bridge) +8.83%
#8 Mantle Staked Ether Mantle Staked Ether +8.33%
#9 MarsCoin MarsCoin +8.26%
#10 Mantle Restaked ETH Mantle Restaked ETH +8.10%
Coin of the day
Islamic Coin Islamic Coin
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
The Greater Cannabis Company, Inc. The Greater Cannabis Company, Inc.

The Greater Cannabis Company, Inc.

GCAN
Peringkat dalam Saham #40153
The Greater Cannabis Company, Inc. engages in the development and... The Greater Cannabis Company, Inc. engages in the development and commercialization of cannabinoid therapeutics. It offers an oral transmucosal patch platform, which provides loaded actives absorbed by the buccal mucosa into the body. The company has a license agreement with Shaare Zedek Scientific Ltd. that focuses on treatment of autism, schizophrenia, Parkinson’s disease, Alzheimer’s disease, and other neuropsychiatric disorders. The company was founded in 2014 and is based in Baltimore, Maryland.
Harga Saham
$0.2301
Terakhir disinkronkan: 2026-08-12
Kapitalisasi Pasar
$228.81K
Perubahan (1 hari)
-17.82%
Perubahan (1 tahun)
95,775.00%
Negara
US
Perdagangan The Greater Cannabis Company, Inc. (GCAN)

Kategori

Healthcare
Pendapatan untuk The Greater Cannabis Company, Inc. (GCAN)
Pendapatan pada Aug 2026 TTM: 0
Menurut laporan keuangan terbaru dari The Greater Cannabis Company, Inc., pendapatan saat ini (TTM) adalah 0. Pada tahun 2026, perusahaan menghasilkan pendapatan sebesar 0 sama dengan pendapatan pada tahun 2026 yang sebesar 0. Pendapatan adalah jumlah total yang dihasilkan dari penjualan barang atau jasa. Tidak seperti laba, tidak ada pengeluaran yang dikurangkan.
Riwayat pendapatan The Greater Cannabis Company, Inc. dari 2026 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Pendapatan untuk perusahaan serupa atau pesaing
Perusahaan Pendapatan Perbedaan Pendapatan Negara
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 $2.54B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 $830.81M -
US